About: Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $19.19 (-5.51%)
DYNNASDAQDyne Therapeutics Inc
Dyne Therapeutics Inc share price
DYN price activity
Último preço
$ 19,190
Variação (24h)
-1,12 USD (-5,51%)
Volume
5.14M
Volume (média 4 sem.)
-
Abertura
$ 19,38
Variação do dia
$ 18,97 - $ 20,16
Fechamento anterior
$ 20,31
Último negócio
09 Sep, 8:06 pm GMT+0
Atrasado
09 Sep, 8:06 pm GMT+0
DYN price performance
Atrasado
09 Sep, 8:06 pm GMT+0
quote.marketSignals